Peter J. Fromen
Amministratore Delegato presso Biomodal Ltd.
Posizioni attive di Peter J. Fromen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 18/07/2022 | - |
| Amministratore Delegato | 18/07/2022 | - |
Storia della carriera di Peter J. Fromen
Precedenti posizioni note di Peter J. Fromen
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Corporate Officer/Principal | 08/01/2021 | 20/05/2022 |
| ILLUMINA, INC. | Contatto Relazioni con gli Investitori | 03/06/2011 | - |
| Public Communications Contact | 01/01/2007 | 24/05/2011 | |
| Corporate Officer/Principal | - | - | |
| Vendite & Marketing | 24/05/2011 | 03/06/2011 |
Formazione di Peter J. Fromen
| Kenyon College | Undergraduate Degree |
| W.P. Carey School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Peter J. Fromen
- Esperienza
